QIAGEN generated about $2.09 billion of 2025 revenue, $466 million of operating income and $654 million of operating cash flow. The thesis depends on sample-to-insight diagnostics demand, consumables quality, regional exposure, capital discipline and debt-funded portfolio investment.
References
Sources used in this report
SEC datasetSEC company tickers exchange datasetRetrieved 2026-05-20 · Issuer identity, ticker, exchange and CIKSEC APISEC submissions APIRetrieved 2026-05-20 · Filing chronology and company identitySEC XBRL APISEC companyfacts APIRetrieved 2026-05-20 · Financial statement cross-checksAnnual reportFY2025 Form 20-F filed 2026-03-202026 · Annual business, risk and financial baselineInterim reportForm 6-K filed 2026-05-082026 · Latest interim filing chronologyEarnings release filingQ1 2026 press release Form 6-K filed 2026-05-082026 · Recent management-reported earnings contextCurrent reportPreliminary Q1 2026 Form 6-K filed 2026-05-012026 · Recent filing chronologyGovernance filingAGM release Form 6-K filed 2025-06-302025 · Governance and annual meeting context